Ken Griffin Heart Test Laboratories, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Heart Test Laboratories, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 123,086 shares of HSCS stock, worth $658,510. This represents 0.0% of its overall portfolio holdings.
Number of Shares
123,086
Previous 30,895
298.4%
Holding current value
$658,510
Previous $5,000
180.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HSCS
# of Institutions
24Shares Held
1.55MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA192KShares$1.02 Million0.0% of portfolio
-
Tradition Wealth Management, LLC180KShares$965,4870.0% of portfolio
-
Northern Trust Corp Chicago, IL165KShares$884,7450.0% of portfolio
-
Hrt Financial LP New York, NY122KShares$655,1870.0% of portfolio
-
Hcr Wealth Advisors Los Angeles, CA100KShares$535,0000.0% of portfolio
About Heart Test Laboratories, Inc.
- Ticker HSCS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,202,550
- Market Cap $43.9M
- Description
- Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urg...